ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $668,000 | -3.9% | 34,524 | -1.3% | 0.66% | +5.7% |
| Q2 2022 | $695,000 | -34.4% | 34,991 | -1.4% | 0.63% | -13.1% |
| Q1 2022 | $1,059,000 | +17.8% | 35,488 | -8.1% | 0.72% | +22.7% |
| Q4 2021 | $899,000 | -16.0% | 38,601 | +12.5% | 0.59% | -13.4% |
| Q3 2021 | $1,070,000 | +21.3% | 34,301 | +36.7% | 0.68% | +21.0% |
| Q2 2021 | $882,000 | +90.9% | 25,097 | +91.7% | 0.56% | +79.9% |
| Q1 2021 | $462,000 | +15.5% | 13,094 | +22.8% | 0.31% | +17.7% |
| Q4 2020 | $400,000 | – | 10,661 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 480,000 | $14,318,000 | 9.25% |
| Decheng Capital Management III (Cayman), LLC | 518,342 | $15,462,000 | 4.74% |
| TANG CAPITAL MANAGEMENT LLC | 467,702 | $13,952,000 | 2.79% |
| Birchview Capital, LP | 113,000 | $3,371,000 | 2.43% |
| Privium Fund Management B.V. | 351,805 | $10,494,000 | 2.32% |
| Sio Capital Management, LLC | 144,546 | $4,312,000 | 1.43% |
| Perceptive Advisors | 2,360,139 | $70,403,000 | 1.41% |
| Chicago Capital, LLC | 1,011,744 | $30,180,000 | 1.30% |
| Endurant Capital Management LP | 120,834 | $3,604,000 | 0.95% |
| Nicholas Investment Partners, LP | 439,235 | $13,102,000 | 0.93% |